The Enhanced External CounterPulsation(EECP) is developed by our department, and we own the intellectual property.EECP is now globally accepted as a treatment protocol for coronary artery disease.

• 我们开发并拥有独立知识产权的增强型体外反搏治疗冠心病的技术具有良好的效果，已在全球广泛应用。